| NCT ID | NCT06786793 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jagiellonian University |
| Condition | Quality Indicators, Health Care |
| Study Type | INTERVENTIONAL |
| Enrollment | 630 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 630 participants in total. It began in 2024-11-01 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Colorectal cancer is the second most common malignancy in the countries of the European Union. Colonoscopy is the primary method for detecting and preventing the development of colorectal cancer is endoscopic examination. This study aims to evaluate the impact of artificial intelligence on the detection rate of polyps and early stages of colorectal cancer.
Eligibility Criteria
Inclusion Criteria: * Consent to participate in the study, * Age between 50 and 65 years, * Scheduled outpatient colonoscopy. Exclusion Criteria: * Previous colonoscopy, * History of colorectal surgery, * Ongoing biological therapy for any indication, * Primary sclerosing cholangitis, * Familial polyposis syndrome, * Chronic diarrhea, * Ulcerative colitis, * Crohn's disease.
Contact & Investigator
Miroslaw Szura, Prof.
STUDY CHAIR
Jagiellonian University in Krakow
Frequently Asked Questions
Who can join the NCT06786793 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 65 Years, studying Quality Indicators, Health Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06786793 currently recruiting?
Yes, NCT06786793 is actively recruiting participants. Contact the research team at z.orzeszko@bonifratrzy.krakow.pl for enrollment information.
Where is the NCT06786793 trial being conducted?
This trial is being conducted at Krakow, Poland, Krakow, Poland.
Who is sponsoring the NCT06786793 clinical trial?
NCT06786793 is sponsored by Jagiellonian University. The principal investigator is Miroslaw Szura, Prof. at Jagiellonian University in Krakow. The trial plans to enroll 630 participants.